日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines

尽管有高质量证据支持，但仍进行超适应症用药：常用非专利抗癌药物的临床实践回顾

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2022.100604
Zarkavelis, G; Amylidi, A L; Verbaanderd, C; Cherny, N I; Metaxas, Y; de Vries, E G E; Zygoura, P; Amaral, T; Jordan, K; Strijbos, M; Dafni, U; Latino, N; Galotti, M; Lordick, F; Giuliani, R; Pignatti, F; Pentheroudakis, G
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Leading the way together: a cluster randomised controlled trial of the 5R Shared Leadership Program in older adult walking groups

携手引领：一项针对老年人步行小组的5R共享领导力项目的整群随机对照试验

期刊:International Journal of Behavioral Nutrition and Physical Activity
影响因子:5.5
doi:10.1186/s12966-022-01297-x
Fransen, Katrien; Cruwys, Tegan; Haslam, Catherine; Iserbyt, Peter; Seghers, Jan; Vanderlinden, Julie; van Uffelen, Jannique; Verbaanderd, Elvire; Boen, Filip
发表日期：2022
文献求助 收藏

How to balance valuable innovation with affordable access to medicines in Belgium?

如何在比利时实现有价值的创新与药品价格可承受性之间取得平衡？

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2022.960701
Simoens, Steven; Abdallah, Khadidja; Barbier, Liese; Lacosta, Teresa Barcina; Blonda, Alessandra; Car, Elif; Claessens, Zilke; Desmet, Thomas; De Sutter, Evelien; Govaerts, Laurenz; Janssens, Rosanne; Lalova, Teodora; Moorkens, Evelien; Saesen, Robbe; Schoefs, Elise; Vandenplas, Yannick; Van Overbeeke, Eline; Verbaanderd, Ciska; Huys, Isabelle
发表日期：2022
文献求助 收藏

Extension of Indication for Authorised Oncology Products in the European Union: A Joint Effort of Multiple Stakeholders

欧盟已获批准肿瘤产品适应症的扩展：多方利益相关者的共同努力

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2021.790782
Mulder, Jorn; Verjans, Robin; Verbaanderd, Ciska; Pean, Elias; Weemers, Just; Leufkens, Hubert G M; Pignatti, Francesco; de Boer, Anthonius; Voest, Emile E; Stoyanova-Beninska, Violeta V; Pasmooij, Anna M G
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research

探索现有药物的新用途：为独立临床研究提供资金的创新机制

期刊:Trials
影响因子:2
doi:10.1186/s13063-021-05273-x
Verbaanderd, Ciska; Rooman, Ilse; Huys, Isabelle
发表日期：2021
文献求助 收藏

Baseline sensorimotor GABA levels shape neuroplastic processes induced by motor learning in older adults

老年人基线感觉运动GABA水平影响运动学习诱发的神经可塑性过程

期刊:Human Brain Mapping
影响因子:3.3
doi:10.1002/hbm.25041
King, Bradley R; Rumpf, Jost-Julian; Verbaanderd, Elvire; Heise, Kirstin F; Dolfen, Nina; Sunaert, Stefan; Doyon, Julien; Classen, Joseph; Mantini, Dante; Puts, Nicolaas A J; Edden, Richard A E; Albouy, Geneviève; Swinnen, Stephan P
发表日期：2020
文献求助 收藏

Sharing of Clinical Trial Data and Samples: The Cancer Patient Perspective

临床试验数据和样本共享：癌症患者的视角

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2020.00033
Broes, Stefanie; Verbaanderd, Ciska; Casteels, Minne; Lacombe, Denis; Huys, Isabelle
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients

适应症内还是适应症外？克服监管和财务障碍，将老药新用带给癌症患者

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2019.01664
Verbaanderd, Ciska; Rooman, Ilse; Meheus, Lydie; Huys, Isabelle
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏

ReDO_DB: the repurposing drugs in oncology database

ReDO_DB：肿瘤药物再利用数据库

期刊:Ecancermedicalscience
影响因子:1.3
doi:10.3332/ecancer.2018.886
Pantziarka, Pan; Verbaanderd, Ciska; Sukhatme, Vidula; Rica Capistrano, I; Crispino, Sergio; Gyawali, Bishal; Rooman, Ilse; Van Nuffel, An Mt; Meheus, Lydie; Sukhatme, Vikas P; Bouche, Gauthier
肿瘤
肿瘤免疫
发表日期：2018
文献求助 收藏

Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents

肿瘤药物再利用（ReDO）——氯喹和羟氯喹作为抗癌药物

期刊:Ecancermedicalscience
影响因子:1.3
doi:10.3332/ecancer.2017.781
Verbaanderd, Ciska; Maes, Hannelore; Schaaf, Marco B; Sukhatme, Vikas P; Pantziarka, Pan; Sukhatme, Vidula; Agostinis, Patrizia; Bouche, Gauthier
肿瘤
肿瘤免疫
发表日期：2017
文献求助 收藏